This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 146 words of the full text and any section headings.

To the Editor: I am concerned that Dr Annane and colleagues¹ studied a highly selected subgroup of the entire population of septic patients. Of the more than half million patients estimated to have severe sepsis in the United States annually,² only a small fraction would have vasopressor- and ventilator-dependent septic shock with documented relative adrenal insufficiency within 1 to 8 hours of the onset of septic shock. Remarkably, only 24% of the patients in this study were bacteremic, yet they experienced an exceedingly high mortality rate of 55% to 61%. The majority of patients had a community-acquired infection with a nonfatal underlying disease state. Such patients should receive optimal supportive care and should have reversible disease physiology. It remains unclear whether corticosteroids benefit a more heterogeneous population with serious underlying diseases or nosocomial infections.

Steven M. Opal, MD
Department of Medicine
Brown Medical School
Providence, RI

1. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871. FREE FULL TEXT 2. Angus DC, Winde-Ziirble WT, Lidicker J, Clermont G, Caricillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310. FULL TEXT | WEB OF SCIENCE | PUBMED

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289:41-42.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Corticosteroids for Patients With Septic Shock
Julian M. Brown
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Christina L. Schenarts and Juan A. March
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Julian Millo
JAMA. 2003;289(1):41.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Jan G. Zijlstra, Iwan C. C. van der Horst, Jaap E. Tulleken, Tjip S. van der Werf, and Jack J. M. Ligtenberg
JAMA. 2003;289(1):42.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
David R. Williamson, Martin Albert, and Marco Charneux
JAMA. 2003;289(1):42.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Babak Mokhlesi
JAMA. 2003;289(1):43.
EXTRACT | FULL TEXT  

Corticosteroids for Patients With Septic Shock
Djillali Annane, Véronique Sebille, and Eric Bellissant
JAMA. 2003;289(1):43-44.
EXTRACT | FULL TEXT  

Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
Djillali Annane, Véronique Sébille, Claire Charpentier, Pierre-Edouard Bollaert, Bruno François, Jean-Michel Korach, Gilles Capellier, Yves Cohen, Elie Azoulay, Gilles Troché, Philippe Chaumet-Riffaut, and Eric Bellissant
JAMA. 2002;288(7):862-871.
ABSTRACT | FULL TEXT